"I wouldn't be here if I had not done the test," he said. Prostate Cancer UK said current NHS guidelines meant it "was each ...

Over the past decade, a growing network of organizations in the world, the nation, the state and the region have transformed the month ...

A new artificial intelligence tool developed by the Hospital Clínic de Barcelona will facilitate the diagnosis of prostate ...

William Boruett ,86, a Cancer survivor from Eldama Ravine displays his book titled “Cancer is Not a Death Sentence” on ...

Prostate cancer affects men all over the world and cutting edge research and clinical trials are happening right here in ...

A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

There is still no official national screening programme for prostate cancer, and clinicians have had to rely on the PSA blood test even though it is notoriously unreliable. A few years ago ...

If you have any of these signs, you should see your doctor as soon as possible. Learn more about prostate cancer from the National Cancer Institute. Huntsman Cancer Institute’s Urologic Cancers ...

The new therapy combines two existing cancer drugs, enzalutamide and talazoparib. Enzalutamide, known by its brand name XTANDI, has been used as a treatment for metastatic castration-resistant ...

AstraZeneca's PARP inhibitor Lynparza should not be made available routinely on the NHS n England and Wales as a treatment for prostate cancer ... and there is no comparative data with docetaxel ...

New research from Cold Spring Harbor Labs shows that a compound related to vitamin K slowed the progression of prostate cancer in lab mice, offering a path for further study into one of the most ...